Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry

Background: The particular challenge in dealing with patients with thromboembolic antiphospholipid syndrome (APS) is to establish an adequate therapy regime, as patients suffer from an increased risk of relapse despite antithrombotic treatment (ATT). Vitamin K antagonists (VKA) are the standard medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Annabel, Herrmann, Eva, Ott, Olivia, Lindhoff-Last, Edelgard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409774/
https://www.ncbi.nlm.nih.gov/pubmed/36013082
http://dx.doi.org/10.3390/jcm11164845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409774/
https://www.ncbi.nlm.nih.gov/pubmed/36013082
http://dx.doi.org/10.3390/jcm11164845

Ejemplares similares